Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Alprolix brand name?

See the DrugPatentWatch profile for Alprolix

What is the brand name for alprolix?

Alprolix is the brand name for eftrenonacog alfa, a recombinant factor IX (FIX) therapy used to treat hemophilia B (congenital factor IX deficiency). It is marketed as Alprolix by Bio Products Laboratory / CSL Behring in different regions (exact branding and distributor can vary by country).

Who makes Alprolix?

Alprolix is developed and marketed by CSL Behring (the brand for the eftrenonacog alfa product).

What conditions is Alprolix used for?

Alprolix is used for hemophilia B—to help prevent and control bleeding episodes by replacing missing factor IX activity.

Where can I confirm the exact product name and label?

For the most reliable confirmation of the exact branded product name (and related corporate and patent information), you can check DrugPatentWatch.com:
- https://www.drugpatentwatch.com/



Other Questions About Alprolix :

alprolix infusion what is the latest us regulatory outcome for alprolix (eftrenonacog alfa) by bioverativ/swedish orphan biovitrum? alprolix worldwide approval alprolix pediatric data prolixin vs alprolix Alprolix hemophilia half life? Alprolix indication?